Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




FDA Approves Intermezzo, First Drug for Early WakeningFDA Approves Intermezzo, First Drug for Early
Link ID 38392
Title FDA Approves Intermezzo, First Drug for Early WakeningFDA Approves Intermezzo, First Drug for Early
Url http://www.medscape.com/viewarticle/754201?src=rsshttp://www.medscape.com/viewarticle/754201?src=rss
Description The FDA announced approval today a new formulation of zolpidem (Intermezzo) for insomnia characterized by middle-of-the-night wakening followed by difficulty returning to sleep. FDA Approvals
Category Articles > Neurology and Neurosurgery
Keywords
Date Nov 24, 2011
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Neurology and Neurosurgery
1. Reduced Connectivity Between Brain Hemispheres With Age Impairs Motor Function
  Increased age-related interhemispheric "cross-talk" slows response time to motor tasks, imaging study shows. Medscape Medical News
Category:   Articles > Neurology and Neurosurgery


2. Stroke Risk Factors Predict Cognitive DeclineStroke Risk Factors Predict Cognitive Decline
  High blood pressure, diabetes, and other known risk factors for stroke also heighten the risk of developing memory problems, report researchers. Medscape Medical News
Category:   Articles > Neurology and Neurosurgery


3. Cellular Injury and Neuroinflammation in Children With Chronic Intractable Epilepsy
  As part of this study, the authors quantified cell death, astrocyte proliferation, microglial activation, and cytokine release in brain tissue from patients who underwent epilepsy surgery. Journal of Neuroinflammation
Category:   Articles > Neurology and Neurosurgery


4. Neonatal Vitamin D Status May Predict Schizophrenia Risk
  Both low and high levels of neonatal vitamin D are linked to an increased risk for schizophrenia development, according to a new case-control study from Danish and Australian researchers. Medscape Medical News
Category:   Articles > Neurology and Neurosurgery


5. Fingolimod Improves Outcomes in Relapsing MS
  New data show fingolimod reduces relapse rates, the risk of 3-month confirmed disability progression, and active disease in patients with relapsing MS. br / iMedscape Medical News/i
Category:   Articles > Neurology and Neurosurgery




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS